Literatur
Naik-Mathuria et al. Wound Repair Regen. 2008;16(2):266–73
Pilling et al. J Immunol. 2003;171(10)5537–46
Moreira et al. J Allergy Clin Immunol. 2010;126(4)712–721.e7
Murray et al. Int J Biochem Cell Biol. 2011;43(1)154–62
Murray et al. PLoS One. 2010;5(3)e9683
Pilling et al. J Immunol. 2007;179(6)4035–44
Dillingh et al. Pulm Pharmacol Ther. 2013;26(6)672–6
Van den Blink et al. Eur Respir J. 2016;47(3)889–97
DuBois et al. 2011
Originalie
Raghu G, van den Blink B, Hamblin MJ et al. Effect of Recombinant Human Pentraxin 2 vs Placebo on Change in Forced Vital Capacity in Patients With Idiopathic Pulmonary Fibrosis: A Randomized Clinical Trial. JAMA. 2018;319(22):2299—307
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Markart, P., Günther, A. Positive Effekte durch Pentraxin 2 auf Lungenfunktion bei IPF. Pneumo News 11, 15–16 (2019). https://doi.org/10.1007/s15033-019-1125-x
Published:
Issue Date:
DOI: https://doi.org/10.1007/s15033-019-1125-x